首页 | 本学科首页   官方微博 | 高级检索  
     


GLP-1 as a target for therapeutic intervention
Affiliation:1. Department of Cardiology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria;2. Department of Pharmacology, School of Medicine, University of California Davis, Genome Building, 451 Health Sciences Drive, Davis, CA 95616, USA;3. Department of Cardiology, Charité-Universitaetsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany;4. Division of Endocrinology and Metabolism, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria;5. Division of Cardiac Surgery, Department of Surgery, Medical University of Graz, Auenbruggerplatz 29, 8036 Graz, Austria;6. Safety Pharmacology, Worldwide Research and Development, Pfizer Inc., Groton, CT 06340, United States;7. Cardiovascular and Metabolic Diseases Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, MA 02139, United States;8. Worldwide Medicinal Chemistry, Worldwide Research and Development, Pfizer Inc., Cambridge, MA 02139, United States
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号